Skip to main content

Table 1 Clinical and demographic data of the studied patients

From: Can positron emission tomography–computed tomography-based three target lesions' total lesion glycolysis predict therapeutic response in Hodgkin Lymphoma?

n = 40

 Age, median (range)

30.5 years (19–85 years)

Gender

 Male

21

 Female

19

B symptoms

 Positive

24

 Negative

16

LDH

 Normal

4

 Elevated

36

ESR

 Normal

0

 Elevated

40

Ann Arbor stage

 I

8

 II

18

 III

6

 IV

8

Histology

 Nodular sclerosis

24

 Mixed cellularity

16

Target lesions

 LNs

75

 Other lesions

17

 Splenic lesions

10

 Bone lesions

8

RECIL response to CTH

 Complete response

26

 Partial response*

8

 Minor response**

4

 Stable disease

0

 Progressive disease

2

  1. *Partial Response means 30% or more reduction of the summation of longest dimensions of the target lesions but not a complete response with Positive FDG-PET findings
  2. **Minor Response means between 10 and 30% reduction of the summation of longest dimensions of the target lesions with FDG-PET findings